141 related articles for article (PubMed ID: 26919859)
1. Three-year monitoring of serum p53 antibody during chemotherapy and surgery for stage IV rectal cancer.
Suzuki T; Shimada H; Ushigome M; Koike J; Funahashi K; Nemoto T; Kaneko H
Clin J Gastroenterol; 2016 Apr; 9(2):55-8. PubMed ID: 26919859
[TBL] [Abstract][Full Text] [Related]
2. Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.
Shimada H; Nagata M; Cho A; Takiguchi N; Kainuma O; Soda H; Ikeda A; Nabeya Y; Yajima S; Yamamoto H; Sugiyama T; Itami M
Surg Today; 2014 Oct; 44(10):1957-61. PubMed ID: 24241479
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.
Lechpammer M; Lukac J; Lechpammer S; Kovacević D; Loda M; Kusić Z
Int J Colorectal Dis; 2004 Mar; 19(2):114-20. PubMed ID: 14634775
[TBL] [Abstract][Full Text] [Related]
4. Serum p53 antibody as a useful marker for monitoring of treatment of superficial colorectal adenocarcinoma after endoscopic resection.
Takeda A; Shimada H; Nakajima K; Yoshimura S; Suzuki T; Asano T; Ochiai T; Isono K
Int J Clin Oncol; 2001 Feb; 6(1):45-9. PubMed ID: 11706527
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
[TBL] [Abstract][Full Text] [Related]
6. Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery.
Murayama K; Nanami T; Suzuki T; Oshima Y; Yajima S; Nemoto T; Shimada H
Clin J Gastroenterol; 2017 Aug; 10(4):357-360. PubMed ID: 28540696
[TBL] [Abstract][Full Text] [Related]
7. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery.
Oshima Y; Suzuki T; Yajima S; Nanami T; Shiratori F; Funahashi K; Shimada H
Surg Today; 2020 Nov; 50(11):1402-1408. PubMed ID: 32458231
[TBL] [Abstract][Full Text] [Related]
8. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
[TBL] [Abstract][Full Text] [Related]
9. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
10. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
[TBL] [Abstract][Full Text] [Related]
11. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
[TBL] [Abstract][Full Text] [Related]
12. Circulating p53 antibody in patients with colorectal cancer: relation to clinicopathologic features and survival.
Shiota G; Ishida M; Noguchi N; Oyama K; Takano Y; Okubo M; Katayama S; Tomie Y; Harada K; Hori K; Ashida K; Kishimoto Y; Hosoda A; Suou T; Kanbe T; Tanaka K; Nosaka K; Tanida O; Kojo H; Miura K; Ito H; Kaibara N; Kawasaki H
Dig Dis Sci; 2000 Jan; 45(1):122-8. PubMed ID: 10695624
[TBL] [Abstract][Full Text] [Related]
13. [A case of metastatic lung and liver tumors from rectal cancer treated with oral UFT and CPT-11 by hepatic arterial infusion followed by FOLFOX and FOLFIRI].
Hoshikawa K; Aoki K; Noda H; Oyama K; Nitta H; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1965-7. PubMed ID: 19011353
[TBL] [Abstract][Full Text] [Related]
14. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
15. [A case of rectal cancer treated with aggressive surgery for liver and anal metastases].
Tsukamoto Y; Ohshima H; Katsumori T; Hamaguchi H; Yamamoto S; Iwanaga T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1796-8. PubMed ID: 25731333
[TBL] [Abstract][Full Text] [Related]
16. [Three Cases of Stage Ⅳ Low Rectal Cancer with Lateral Pelvic Lymph Node Metastasis].
Tamura H; Shimada Y; Yagi R; Tajima Y; Okamura T; Nakano M; Ishikawa T; Sakata J; Kobayashi T; Kameyama H; Kosugi S; Wakai T; Nogami H; Maruyama S; Takii Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2303-5. PubMed ID: 26805345
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical Reductions in Serum Anti-p53 Autoantibody Levels by Chemotherapy in Unresectable Colorectal Cancer: An Observational Study.
Nozawa H; Ishihara S; Kawai K; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Watanabe T
Oncology; 2016; 91(3):127-34. PubMed ID: 27362767
[TBL] [Abstract][Full Text] [Related]
18. [5-FU/LV therapy for a rectal cancer patient undergoing continuous hemodialysis with multiple hepatic metastases--a case report].
Katayama K; Nagamine Y; Kajiura K; Kohagura F; Shinzato S
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1213-6. PubMed ID: 18633266
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
20. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
